- 2025-04-12 17:33CSK substrate
- 2025-04-12 17:33(-)-Pinocembrin ((-)-Pinocembrin) 206660-42-6
- 2025-04-12 17:33(Rac)-SAR131675 1092539-44-0
- 2025-04-12 17:33(6R,7S)-Cefminox sodium heptahydrate 92636-39-0
- 2025-04-12 17:33(R)-NX-2127 3024312-52-2
- 2025-04-12 17:33(2R,3S)-Fmoc-Abu(3-N3)-OH 1932349-21-7
- 2025-04-12 17:33LASV inhibitor 3.3 554438-52-7
- 2025-04-12 17:332-Hydroxytetradecanoic acid 2507-55-3
- 2025-04-12 17:33ADC Control Human IgG1-DM4
- 2025-04-12 17:33ABBV-303
- 2025-04-12 17:33ALK-IN-12 1197958-53-4
- 2025-04-12 17:33A17 2568186-47-8
- 2025-04-12 17:33SB-734117 607368-97-8
- 2025-04-12 17:33(Rac)-JBJ-04-125-02 acetate
- 2025-04-12 17:33GNF-5 778277-15-9
- 2025-04-12 17:33Asebogenin 520-42-3
- 2025-04-12 17:33Antiviral agent 59
- 2025-04-12 17:33GP(33-41) 161928-86-5
- 2025-04-12 17:33Antitumor agent-165
- 2025-04-12 17:33Cisplatin/Dasatinib prodrug-1
